Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma.
作者信息
Qiao Bin, Li Shuaize, Wang Die, Wu Di
机构信息
Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Centre for Cancer Research, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
出版信息
Front Oncol. 2022 Apr 6;12:874353. doi: 10.3389/fonc.2022.874353. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma.社论：口腔和食管鳞状细胞癌的遗传学与分子机制
Front Oncol. 2022 Apr 6;12:874353. doi: 10.3389/fonc.2022.874353. eCollection 2022.
2
Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.新型候选基因可能是家族性食管鳞状细胞癌全外显子测序揭示的潜在致病因素。
Tumour Biol. 2017 May;39(5):1010428317699115. doi: 10.1177/1010428317699115.
3
Genome Sequencing in Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌的基因组测序。
Methods Mol Biol. 2020;2129:217-240. doi: 10.1007/978-1-0716-0377-2_17.
4
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.食管鳞状细胞癌的基因组特征：来自下一代测序的见解
World J Gastroenterol. 2016 Feb 21;22(7):2284-93. doi: 10.3748/wjg.v22.i7.2284.
5
Personalized targeted therapy for esophageal squamous cell carcinoma.食管鳞状细胞癌的个性化靶向治疗
World J Gastroenterol. 2015 Jul 7;21(25):7648-58. doi: 10.3748/wjg.v21.i25.7648.
6
Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.通过多区域全外显子组测序对食管鳞状细胞癌及其癌前病变进行基因组比较。
Nat Commun. 2017 Sep 12;8(1):524. doi: 10.1038/s41467-017-00650-0.
7
Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.食管鳞状细胞癌（ESCC）的基因组分析——精准医学的基础
Pathol Res Pract. 2017 Jul;213(7):836-841. doi: 10.1016/j.prp.2017.02.021. Epub 2017 Feb 28.
8
Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.口腔鳞状细胞癌的外显子组测序揭示分子亚组和新的治疗机会。
Theranostics. 2017 Feb 26;7(5):1088-1099. doi: 10.7150/thno.18551. eCollection 2017.
9
An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.一则重述的旧故事：G1 调控缺失定义了食管鳞状细胞癌的一种独特基因组亚型。
Genomics Proteomics Bioinformatics. 2015 Aug;13(4):258-70. doi: 10.1016/j.gpb.2015.06.003. Epub 2015 Sep 16.
10
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.迈向精准医学在头颈部鳞状细胞癌治疗中的应用。
Oncotarget. 2017 Jan 10;8(2):2141-2152. doi: 10.18632/oncotarget.13798.
本文引用的文献
1
Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment.免疫检查点抑制剂与标准放化疗在头颈癌根治性治疗中的应用
J Pers Med. 2021 May 10;11(5):393. doi: 10.3390/jpm11050393.
2
Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.破坏 HER3-PI3K-mTOR 致癌信号通路和 PD-1 阻断作为头颈癌的多模式精准免疫治疗。
Nat Commun. 2021 Apr 22;12(1):2383. doi: 10.1038/s41467-021-22619-w.
3
Head and Neck Cancer.头颈癌
N Engl J Med. 2020 Jan 2;382(1):60-72. doi: 10.1056/NEJMra1715715.
4
TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.TRIM67 通过激活 p53 抑制结直肠肿瘤的发生和发展。
Cancer Res. 2019 Aug 15;79(16):4086-4098. doi: 10.1158/0008-5472.CAN-18-3614. Epub 2019 Jun 25.
5
An update: emerging drugs to treat squamous cell carcinomas of the head and neck.更新：治疗头颈部鳞状细胞癌的新兴药物。
Expert Opin Emerg Drugs. 2018 Dec;23(4):283-299. doi: 10.1080/14728214.2018.1543400. Epub 2018 Nov 16.
6
Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes.双靶点 Aurora 激酶抑制剂 AMG 900 对急性髓系白血病具有强大的临床前活性，并产生独特的有丝分裂后结局。
Mol Cancer Ther. 2018 Dec;17(12):2575-2585. doi: 10.1158/1535-7163.MCT-18-0186. Epub 2018 Sep 28.
7
Tumor Mutational Burden and Response Rate to PD-1 Inhibition.肿瘤突变负荷与对PD-1抑制的反应率
N Engl J Med. 2017 Dec 21;377(25):2500-2501. doi: 10.1056/NEJMc1713444.
8
Recent omics technologies and their emerging applications for personalised medicine.近期的组学技术及其在个性化医疗中的新兴应用。
IET Syst Biol. 2017 Jun;11(3):87-98. doi: 10.1049/iet-syb.2016.0016.
9
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.叉头框蛋白M1招募细胞核极光激酶A以参与乳腺癌干细胞自我更新所必需的正反馈循环。
Oncogene. 2017 Jun 15;36(24):3428-3440. doi: 10.1038/onc.2016.490. Epub 2017 Jan 23.
10
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.帕博利珠单抗在生物标志物未筛选的复发和/或转移性头颈部鳞状细胞癌患者中的抗肿瘤活性：Ib期KEYNOTE-012扩展队列研究结果
J Clin Oncol. 2016 Nov 10;34(32):3838-3845. doi: 10.1200/JCO.2016.68.1478. Epub 2016 Sep 30.
Zotero 插件